Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.724
+0.004 (0.50%)
At close: Mar 9, 2026, 4:00 PM EDT
0.738
+0.014 (1.99%)
After-hours: Mar 9, 2026, 4:48 PM EDT
Skye Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 23 | 86 | 34 | 15 | 25 | 11 | |
| Market Cap Growth | -75.57% | 155.60% | 126.97% | -40.22% | 130.88% | -42.17% | |
| Enterprise Value | -12 | 19 | 33 | 17 | 16 | 8 | |
| Last Close Price | 0.72 | 2.83 | 2.72 | 4.05 | 13.00 | 10.00 | |
| PB Ratio | 0.68 | 1.26 | -15.76 | -4.92 | 4.22 | 23.79 | |
| P/TBV Ratio | 0.70 | 1.26 | - | - | 4.22 | 23.79 | |
| Debt / Equity Ratio | 0.01 | 0.01 | -2.16 | -0.66 | 0.36 | 3.32 | |
| Net Debt / Equity Ratio | -1.07 | -1.00 | -1.58 | -0.22 | -1.17 | -2.15 | |
| Net Debt / EBITDA Ratio | 0.66 | 2.27 | -0.25 | -0.04 | 0.88 | 0.16 | |
| Net Debt / FCF Ratio | 0.84 | 2.53 | -0.24 | -0.05 | 1.04 | 0.16 | |
| Quick Ratio | 4.22 | 15.77 | 0.14 | 0.12 | 2.30 | 3.14 | |
| Current Ratio | 4.77 | 16.32 | 0.84 | 0.74 | 2.46 | 3.39 | |
| Return on Equity (ROE) | -94.31% | -80.48% | - | -1364.20% | -269.91% | -1313.66% | |
| Return on Assets (ROA) | -54.88% | -44.56% | -80.28% | -120.69% | -78.31% | -168.39% | |
| Return on Invested Capital (ROIC) | - | -4257.10% | - | - | - | - | |
| Return on Capital Employed (ROCE) | -163.70% | -44.10% | 689.60% | 608.80% | -132.10% | -333.70% | |
| Earnings Yield | -221.83% | -30.94% | -112.07% | -131.64% | -34.42% | -61.18% | |
| FCF Yield | -179.81% | -31.26% | -41.57% | -86.75% | -26.52% | -56.53% | |
| Buyback Yield / Dilution | -34.31% | -420.79% | -215.43% | -36.56% | -75.70% | -36.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.